Variability in German Cockroach Extract Composition Greatly Impacts T Cell Potency in Cockroach-Allergic Donors by �젙寃쎌슜
ORIGINAL RESEARCH
published: 27 February 2019
doi: 10.3389/fimmu.2019.00313
Frontiers in Immunology | www.frontiersin.org 1 February 2019 | Volume 10 | Article 313
Edited by:
Craig Michael Schramm,
University of Connecticut,
United States
Reviewed by:
Dominique M. A. Bullens,
KU Leuven, Belgium
Roger Steven Thrall,
University of Connecticut Health
Center, United States
*Correspondence:
Véronique Schulten
veroniqueschulten44@gmail.com
†Coby Schal
orcid.org/0000-0001-7195-6358
Specialty section:
This article was submitted to
Immunological Tolerance and
Regulation,
a section of the journal
Frontiers in Immunology
Received: 20 June 2018
Accepted: 06 February 2019
Published: 27 February 2019
Citation:
Birrueta G, Frazier A, Pomés A,
Glesner J, Filep S, Schal C, Jeong KY,
McMurtrey C, Vander Schans T,
Hildebrand WH, Busse P,
Beigelman A, Bacharier LB, Peters B,
Sette A and Schulten V (2019)
Variability in German Cockroach
Extract Composition Greatly Impacts
T Cell Potency in Cockroach-Allergic
Donors. Front. Immunol. 10:313.
doi: 10.3389/fimmu.2019.00313
Variability in German Cockroach
Extract Composition Greatly Impacts
T Cell Potency in Cockroach-Allergic
Donors
Giovanni Birrueta 1, April Frazier 1, Anna Pomés 2, Jill Glesner 2, Stephanie Filep 2,
Coby Schal 3†, Kyoung Yong Jeong 4, Curtis McMurtrey 5,6, Thomas Vander Schans 6,
William H. Hildebrand 5, Paula Busse 7, Avraham Beigelman 8, Leonard B. Bacharier 8,
Bjoern Peters 1,9, Alessandro Sette 1,9 and Véronique Schulten 1*
1 La Jolla Institute for Immunology, La Jolla, CA, United States, 2 Indoor Biotechnologies, Inc., Charlottesville, VA,
United States, 3Department of Entomology and Plant Pathology, North Carolina State University, Raleigh, NC, United States,
4Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, South Korea,
5Department of Microbiology and Immunology, University of Oklahoma, Health Sciences Center, Oklahoma City, OK,
United States, 6 Pure MHC, Oklahoma City, OK, United States, 7Division of Clinical Immunology, Icahn School of Medicine at
Mount Sinai School of Medicine, New York, NY, United States, 8Department of Pediatrics, Washington University School of
Medicine, St Louis, MO, United States, 9Department of Medicine, University of California San Diego, La Jolla, CA,
United States
German cockroach extract is used clinically to evaluate allergen-specific sensitization
and for subcutaneous allergen-specific immunotherapy, though there are no guidelines
for standardization in its manufacture. We performed an immunological evaluation of
12 different cockroach extracts prepared from different sources and their potency to
induce allergen-specific T cell reactivity. PBMC from 13 cockroach allergic donors were
expanded in vitro with 12 different German cockroach extracts. After culture expansion,
cells were re-stimulated with the different extracts and T cell responses were assessed by
FluoroSpot (IL-5, IFNγ and IL-10 production). In parallel to the extracts, single allergen
peptide pools for allergens from groups 1, 2, 4, 5, and 11 were tested to determine
allergen immunodominance. Furthermore, to assess allergy specificity, PBMC from 13
non-allergic donors were also tested with the most potent extract and T cell responses
were compared to the allergic cohort. Dramatic variations in T cell reactivity were
observed to the different cockroach extract batches. Response magnitudes varied over
3 logs within a single donor. IL-5 production in the allergic cohort was significantly higher
compared to the non-allergic cohort (p=0.004). Allergen content determination by ELISA
detected much lower concentrations of Bla g 5 compared to Bla g 1 and 2. Mass
spectrometric analysis revealed that Bla g 5 was present in similar amounts to Bla g
1 and 2 in extracts made from whole body, whereas it was not detected in extracts
made from fecal matter, suggesting that Bla g 5 is not excreted into feces. Different
donors exhibit different response patterns to different extracts, potentially dependent on
the donor-specific T cell allergen immunodominance pattern and the allergen content
of the extract tested. These findings have dramatic implications for the selection of
potent extracts used for diagnostic purposes or allergen-specific immunotherapy.
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INTRODUCTION
German Cockroach (Blattella germanica) extract is used for
allergy diagnosis and cockroach-specific immunotherapy (1).
However, there are no guidelines regarding the standardization
of its manufacture and as a result, the extracts can vary
significantly with respect to allergen content. In recent years,
our understanding of cockroach allergen components has grown
significantly leading to a more comprehensive definition of IgE-
reactive Bla g proteins (2–6).
Currently there are 10 different allergens derived from
Blattella germanica (Bla g 1-9 and 11) that are registered
in the World Health Organization/International Union
of Immunological Societies (WHO/IUIS) list of Allergen
Nomenclature database (www.allergen.org) (7). This number
is still increasing as new allergenic targets are being discovered
(8, 9). Structural biology studies investigating the different
allergen components have reported that some cockroach
allergens are likely secreted or excreted (Bla g 1, 2, and 4) while
others, (such as Bla g 6, 7, and 8), are likely only released after
breakdown of the dead insect body (10). In addition, some
allergens are only expressed under specific circumstances: Bla g
4 (lipocalin) for example is only expressed by male cockroaches
during reproductive activity (11).
Because of the lack of standardization of cockroach extract
manufacture despite the complexity of cockroach allergen
components, it is likely that different extracts will vary in terms of
relative content of each allergen component, endotoxin content
and other potentially immune-reactive components. Variability
in extract composition can result from several factors such as the
source material used (whole body vs. feces), cockroach gender
ratios, diet and potentially other factors influencing allergen
expression. Indeed, a study by Patterson et al. focused on Bla g 1
and 2 content, reported major variability of both allergens among
the 24 cockroach extracts analyzed (12).
In contrast to other respiratory allergies such as house
dust mite allergy, cockroach allergies are not associated with
one or two dominant allergens. It has been shown that
IgE reactivity to different allergens varies greatly in different
patients (13, 14). Moreover, we have recently reported that
IgE reactivity varies greatly with different German cockroach
extract batches tested (15). In addition to IgE, type 2 T
helper cells also contribute significantly to the pathology of
allergy and asthma (16). We have previously reported that,
similarly to IgE, the Bla g-specific T cell response was directed
against many different allergens, and further, the pattern
of allergen dominance was donor dependent, with T cell
responses of different donors being dominated by different
allergen specificities (9).
Given the use of extract for diagnosis and specific
immunotherapy for German cockroach allergy, it is desirable
that extracts used in the clinic are potent both in terms of IgE
and T cell reactivity. Here, we analyzed 12 different German
cockroach extracts, acquired from commercial sources as well as
in-house produced extracts, determining their content for Bla
g 1, 2, 4, 5, and 11 and their potency to induce antigen-specific
cytokine production in T cells from cockroach-allergic patients.
MATERIALS AND METHODS
Study Population and PBMC Isolation
Cohorts of 13 individuals sensitized to German cockroach and
13 non-sensitized individuals, as defined by cockroach-specific
IgE titers (≥0.35 kUA/L considered positive) and skin prick
test (≥3mm considered positive), were studied. Donors were
recruited from San Diego, CA, New York City, NY and St. Louis,
MO following Institutional Review Board approval by the La Jolla
Institute’s Institutional Review Board (IRB protocol: VD-112-
0217), Mount Sinai’s Institutional Review Board (IRB protocol:
GCO 13-0691) and Washington University Institutional Review
Board (IRB protocol: 201305110). All subjects enrolled in
this study provided written consent. Donor information is
summarized in Table 1. IgE-titers were determined from
plasma using ImmunoCAP (Thermo Fisher, Uppsala, Sweden).
PBMCs were isolated from whole blood by density gradient
centrifugation according to manufacturers’ instructions (Ficoll-
Hypaque, Amersham Biosciences, Uppsala, Sweden).
German Cockroach Extracts
Twelve different German cockroach extracts acquired or
prepared in-house were used for this study. A summary of
all 12 extracts, their origin and source material as well as
endotoxin content is given in Table 2. Nine of the 12 extracts
TABLE 1 | Clinical information for donor cohorts.
Donor ID CR sIgE (kUA/L) Skin test (mm) Clinical symptoms
1445 76.20 9.0 Severe Asthma
1277 66.20 10.0 Intermittent Asthma
1228 56.50 7.0 Moderate Asthma
1424 45.20 10.0 Severe Asthma
1425 36.00 7.0 Severe Asthma
1398 10.50 8.5 Moderate Asthma
2210 10.13 NT Allergic Rhinitis
1437 8.32 9.0 Mild Asthma
1175 7.27 3.0 Allergic Rhinitis
1406 5.30 4.5 Intermittent Asthma
1864 4.82 NT Asthma
1231 4.47 3.5 Severe Asthma
2083 3.41 NT Allergic Rhinitis
1083 <0.35 0 None
1086 <0.35 0 None
1087 <0.35 0 None
1128 <0.35 0.5 None
1190 <0.35 1 None
1199 <0.35 0 None
1200 <0.35 0 None
1204 <0.35 0 None
1225 <0.35 0 None
1227 <0.35 0 None
1235 <0.35 0 None
1242 <0.35 0 None
1283 <0.35 0 None
NT, not tested.
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were purchased from Greer Laboratories (Lenoir, NC, USA).
Batches from Greer included four extracts labeled for clinical use
in humans, two extracts for veterinarian use and three extracts for
research use. In addition, three different research grade extracts
were manufactured by different research labs. Two different
extracts fromGerman cockroach fecal matter were manufactured
at Yonsei University (Seoul, South Korea), and at the La
Jolla Institute (La Jolla, CA, USA), using established protocols
described elsewhere (8). A third extract was manufactured
from cockroach frass (cockroach debris containing body parts,
fecal material and egg casings) at Indoor Biotechnologies,
Inc. (Charlottesville, VA, USA) by stirring German cockroach
frass for 24-48 hours at 4◦C in Phosphate Buffered Saline
(PBS), pH 7.4 (0.19g frass/ml). The extract was centrifuged
two times and the resulting supernatant was centrifuged before
filtering through a Whatman #1 filter paper and dialyzing in
PBS twice. Finally, the extract was filtered through a 0.22µm
filter unit. Protein concentration for all twelve extracts was
measured using Advanced Protein Assay (APA) (Cytoskeleton
Inc., Denver, CO, USA), following kit instructions provided by
the manufacturer.
Allergen Content Determination by Mass
Spectrometry
Bla g allergens were measured by a trypsin digest LCMS
proteomics workflow. Extracts were digested with trypsin
using the In-solution Tryptic digestion kit (Thermo Scientific,
Waltham, MA, USA). Briefly, 10 µg of whole extract protein
was heat denatured, reduced and alkylated with IAA for 2 h, and
finally digested with trypsin for 3 h at 37◦C followed by 24 h
at 30◦C according to manufacturer’s instructions. Digests were
desalted with Pierce C18 10 µl pipette tips (Thermo Scientific).
Desalted digests were reduced to dryness and resuspended
in 10% v/v acetic acid containing iRT standard peptides
(Biognosys, Schlieren, Switzerland). All samples were digested in
4 independent experiments.
Digests were injected and analyzed by nano-LCMS with an
Eksigent nanoLC400/Sciex 5600 TripleTOF system as previously
described (17, 18). To obtain the tryptic peptide sequences
de novo, one set of trypsin digests was injected and analyzed
using data-dependent acquisition. The resulting spectra were
interpreted using PEAKS 8.0 at a 1% FDR. Data was searched
against all publicly available protein sequences from NCBInr,
Uniprot, TrEMBL for the species B. germanica [6973].
These data were exported to mzXML by PEAKS for use
in Skyline and a fragment spectral library was generated in
Skyline 3. Abundant tryptic peptides from Bla g 1, Bla g 2,
and Bla g 5 were selected for quantitation. Tryptic peptides and
the respective transitions used for analysis are summarized in
Supplemental Table 1.
For the quantitation experiments, the remaining 3 sets of
digests were injected and analyzed using data-independent
acquisition (DIA) or SWATH. The DIA method consisted of 37
experiments per cycle and had a total cycle time of 4.4 s. The first
experiment was an MS1 survey scan from 300 to 1,500 m/z. This
was followed by 36 MS/MS experiments from 350 to 1,250 m/z
with 25 m/z transmission windows each. DIA data were analyzed
using Skyline 3. Three isotopic precursor ions and the top 4 most
abundant product ions (transitions) were selected for each tryptic
peptide (Supplemental Table 1). Retention times were predicted
using the iRT standard peptides and transitions were searched
with an extraction window of 5min of the predicted retention
time. Initial transition peak bounders were manually confirmed.
If no peak was detected for a Bla g peptide, no intensity value
was reported. The sum of the peak area for the 4 product ions
for all the peptides in the Bla g protein was used for quantitation
of the Bla g protein. To account for LCMS variations, areas
between samples were normalized to the sum peak area of the
iRT peptide transitions.
Allergen Content Determination by ELISA
Levels of allergens Bla g 1, Bla g 2, and Bla g 5 were measured
by immunoassays. A two-site ELISA was performed using an
TABLE 2 | German cockroach extract summary showing origin of manufacture, lot numbers, source material, licensed use and Endotoxin content.
Extract Manufacture Item # Lot # Source material Licensed use Endotoxin (EU/ml)
Extract 1 Greer Se05171001-01 n.a. Whole body Human 1,617
Extract 2 Greer XGB46X1A5 294547 Whole body Human 10,892
Extract 3 Greer XGB46X1A10 294546 Whole body Human 3,175
Extract 4 Greer XGB46X1A10 294545 Whole body Human 13,418
Extract 5 Greer XB46X1A50 294544 Whole body Veterinary 467
Extract 6 Greer XGB46X1A50 294548 Whole body Veterinary 3,069
Extract 7 Greer XPB46D3A4 285969 Whole body Research 1,889
Extract 8 Greer XPB46D3A4 259066 Whole body Research 1,546
Extract 9 Greer XPB46D3A4 297511 Whole body Research 13,782
Extract 10 In-house n.a. n.a. Feces Research 342,622
Extract 11 In-house n.a. n.a. Feces Research 152,713
Extract 12 In-house n.a. n.a. Feces/Frass Research 39,934
n.a.-not applicable.
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allergen-specific monoclonal antibody and a polyclonal antibody
for detection as described previously (19, 20).
Endotoxin Content Determination and
Removal
Each cockroach extract was analyzed for endotoxin content as
previously published (15) by using the chromogenic Limulus
Amoebocyte Lysate assay (LAL QCL kit) (Lonza, Basel,
Switzerland) following manufacturer’s guidelines. The extracts
were analyzed at a starting concentration of 1:100 with three 1:5
dilutions up to 1:12,500, and results were reported in endotoxin
units (EU) per milliliter of extract.
Endotoxin was removed from extract 7, by passing it 3 times
over a Pierce High-Capacity Endotoxin Removal Spin Column,
1ml size (ThermoFisher). The extract was divided in half and
3ml each was processed over 2 individual spin columns. The
columns were regenerated and washed as described by the
manufacturer between each column run. The final samples were
assayed for endotoxin levels using a Lonza LAL QCL assay kit as
described above.
PBMC in vitro Cultures
For in vitro cultures, PBMCs were stimulated with either German
cockroach extracts (10µg/ml) or Bla g peptide pools (1µg/ml).
Cells were cultured at a density of 2 × 106 cells per mL of
RPMI 1640 (Omega Scientific, Tarzana, CA, USA) supplemented
with 5% humanAB serum (GemCell; Gemini Bio-Products,West
Sacramento, CA, USA) in a 24-well plate. Cells we incubated at
37◦C with 5% CO2. Every 3 days after initial stimulation, half
of the culture volume (1ml) was removed and 1ml of fresh
medium with IL-2 (10 U/mL; ThermoFisher) was added. After
14 days, cells were harvested and screened for IL-5, IFNγ, and
IL-10 production by Fluorospot.
Fluorospot
IL-5, IFNγ, and IL-10 production after cockroach extract
stimulation was analyzed by Fluorospot assay containing three
fluorophores. Flat-bottom 96-well plates with a low-fluorescent
PVDF membrane (Millipore, Bedford, MA, USA) were prepared
and coated with 5µg/ml anti-human IL-5 (clone TRFK5;
Mabtech, Cincinnati, OH, USA), 5µg/ml anti-human IFNγ
(clone 1-D1K; Mabtech), and 10µg/ml anti-human IL-10 (clone
9D7; Mabtech) according to manufacturer’s instructions. Cells
(1x105 cells/well) stimulated with cockroach extracts were
incubated with the corresponding extract (titrated at 50, 10,
2, and 0.4µg/ml), Bla g peptide pools (1µg/ml), medium
alone and PHA (10µg/ml) as negative and positive controls,
respectively. Cells stimulated with Bla g peptide pools were
incubated with corresponding Bla g pool (1µg/ml), all cockroach
extracts (10µg/ml), medium alone and PHA (10µg/ml) as
a controls. After 24 h at 37◦C, cells were removed and the
plates were incubated at room temperature with detection
antibodies for IL-5 diluted at 1:200 (mAb 5A10-BAM; Mabtech),
IFNγ diluted at 1:200 (mAb 7-B6-1-FS-FITC; Mabtech), and
biotinylated IL-10 Ab at 2µg/ml (Clone 12G8; Mabtech). After
2 h, plates were developed by adding fluorophore conjugates for
IL-5 (anti-BAM-640; Mabtech), IFNγ (anti-FITC-490; Mabtech),
and IL-10 (SA-500; Mabtech) diluted at 1:200. Plates were
then treated with Fluorescence enhancer-II (Mabtech) after
1 h for 15min. Spot forming cells (SFC) were counted by
computer assisted image analysis (AID iSpot ELR07IFL reader;
Strasberg, Germany).
Statistical Analysis
For the raw data analysis of the T cell responses as measured
by Fluorospot, each reading was performed in triplicate for
statistical significance. To determine if a measured response
is significant, we used the following criteria, as previously
published (21).
Criteria for positivity were as follows: (1) A minimum
response of ≥100 SFCs per 106 PBMCs. (2) The T cell reactivity
valuesmeasured in triplicate in response to a given extract needed
to be significantly higher (p < 0.05) compared to background,
as assessed by Student T-test, two-tailed, non-parametric. The
T cell reactivity observed needed to reach a stimulation index
≥2, i.e. have a magnitude at least 2-fold higher than the
background. Finally, cytokine production in response to medium
alone (background levels) were subtracted from all data for
each stimulus.
Statistical analysis comparing T cell responses between allergic
and non-allergic individuals in response to extract 7 was
performed by Mann-Whitney test, non-parametric, two-tailed.
RESULTS
Different Extracts Vary in Bla g
Components and Endotoxin Content
The impact of varying content of German cockroach extracts
on the potency to induce T cell responses has thus far not
been addressed in the literature. Here, we analyzed the allergen
composition and endotoxin content of 12 different extracts
produced by different protocols using either whole body or
cockroach fecal matter as source material.
Measurements of the relative levels of Bla g 1, 2, and 5
revealed high variability for all 3 allergens across the 12 different
extracts (Figure 1). While Bla g 1 was detected in all extracts,
it was observed on average 8.5-fold higher in the extracts made
from German cockroach fecal matter compared to extracts made
from whole body. Less variability was observed for Bla g 2,
which was detected in every extract at levels within one order of
magnitude of each other. Bla g 5 levels were overall much lower
in comparison to Bla g 1 and 2 but were detected to some level
in 10 out of 12 extracts (Figure 1). Specifically, the three fecal
extracts contained little to no Bla g 5, while the extracts used
in humans or for research consistently contained low amounts
of Bla g 5. Interestingly, one of the extracts used in a veterinary
setting contained almost 3 fold more Bla g 5 than the next highest
extract (Figure 1).
In addition to mass spectrometry, we also quantified the
amounts of immunoreactive Bla g 1, 2, and 5 by ELISA
(Supplemental Figure 1). Overall, the contents observed were
similar to the MS analysis. Interestingly, ELISA analysis detected
amounts of Bla g 1 and Bla g 2 100-fold higher compared to
the amounts of Bla g 5 (Supplemental Figure 1). This apparent
discrepancy may indicate that the antibody-based detection of
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conformational epitopes requires correctly folded intact proteins
and is less likely to detect degraded fragments from Bla g 5.
Assessment of endotoxin levels also revealed high variability
ranging from 467 EU/ml in extract 5 (manufactured for
veterinarian use) to 342,622 EU/ml in extract 10, which was
made from fecal matter in-house (Table 2). Overall, endotoxin
levels were highest in the extracts produced from fecal matter
but even when only considering extracts labeled for human
clinical use, endotoxin levels still ranged from 1,617 to 13,418
EU/ml (Table 2).
Different Extracts Vary in T Cell Potency
Next, we set out to investigate the potency of the different extracts
in terms of inducing T cell responses in PBMC from German
cockroach-allergic patients.
At a concentration of 50µg/ml, the total T cell response
magnitude (sum of three cytokines) ranged from 50 to 6304 SFC
(extract 10, extract 7, respectively). Differences in potency are
effectively visualized by dose titrations, indicating the respective
allergen extract concentration required to induce a T cell
reactivity of 500 SFC (Figure 2A). Spontaneous secretion of
cytokines after 14 days of culture in the absence of additional
extract stimulation was also assessed and the data is presented
in Supplemental Table 2. Overall, the different extracts varied in
potency for T cells over 2 log-fold.
Commercial extracts produced for research use were highly
potent, inducing a T cell response of 500 SFC at ∼4µg/ml
(extract 9) or even ≤0.4µg/ml (extract 7 and 8) whereas extracts
made for human or veterinarian clinical use required a dose of
8–50µg/ml to induce a comparable T cell response. Extracts
made from fecal material performed the worst (Figure 2A),
unable to induce the 500 SFC threshold response at a
concentration of 50µg/ml. Extract 12 induced a maximum
T cell reactivity of ∼200 SFC and extracts 10 and 11 were
unable to induce a response above 100 SFC at any tested
concentration. Interestingly, no major differences in cytokine
polarization were observed between IL-5, IFNγ, and IL-10
production (Figures 2B–D).
To evaluate if the responses were allergy-specific, we
performed an analysis comparing T cell reactivity (as assessed
by Fluorospot) in CR allergic and non-allergic individuals, using
the most potent extract (extract 7) as stimulus (Figure 3). The
analysis revealed significantly stronger IL-5 production in the
allergic compared to the non-allergic cohort (median responses:
allergic cohort 3443 SFC vs. non-allergic cohort 1040 SFC, p =
0.004). No significant difference was observed for IFNγ (median
responses: allergic cohort 407 SFC vs. non-allergic cohort 210
SFC, p= 0.21) and IL-10 (median responses: allergic cohort 1820
SFC vs. non-allergic cohort 883 SFC, p= 0.093).
To assess if endotoxin levels in the extracts directly affect their
ability to induce T cell reactivity, we performed a correlation
analysis. Endotoxin levels in the 12 extracts have been previously
reported (15) and are summarized in this manuscript in
Table 2. No correlation between endotoxin content and T cell
reactivity was detected, regardless of whether IL-5 production
alone was considered (R2 = 0.19, p = 0.16) or total cytokine
production (sum of IL-5, IFNγ and IL-10) (R2 = 0.2, p = 0.16)
FIGURE 1 | Quantification of Bla g 1, 2, and 5 in 12 different German
cockroach extracts by mass spectrometry (MS). Bar graphs showing the
content of peptides derived from Bla g 1, 2, and 5 as detected by MS in 12
different extracts, including extracts for human use, veterinary use, research
use and extracts made from German cockroach fecal matter/frass. Bars
indicate median values of triplicate readings and error bars indicate 95%
confidence interval. Of note, all 3 graphs have a different y-axis.
(Supplemental Figures 2A,B). As a second approach, we also
tested extract 7, for which we had a large volume available, before
and after endotoxin removal. T cell reactivity was virtually the
same in response to the extract before (1889 EU/ml) and after
(177 EU/ml) endotoxin removal (Supplemental Figure 2C).
Different Donors Exhibit Varying Bla g
Allergen Dominance at the T Cell Level
While studies on IgE reactivity to individual German cockroach
allergens have reported a wide variability of allergen recognition
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FIGURE 2 | Variability in T cell potency and cytokine polarization in 12 different German cockroach extracts. (A) A line graph showing T cell reactivity (sum of IL-5,
IFNγ, and IL-10 production) in response to 12 different preparations of German cockroach extract, measured in 5-fold titration steps (0.4, 2, 10, and 50µg/ml). A
dotted line indicates potency of extract to induce a T cell response of 500 spot forming cells (SFC). Geometric means 13 tested donors are shown, with error bars
indicated 95% confidence interval (CI). (B–D) Bar graphs showing the IL-5, IFNγ, and IL-10 production. Bars indicate geometric means of 13 donors, with error bars
indicating 95% CI. N = 13.
FIGURE 3 | T cell reactivity measured as spot producing cells (SFC) in allergic
(black dots) and non-allergic (open circles) individuals in response to extract 7.
Bars indicate geometric means, error bars represent 95% confidence intervals.
Statistical comparison was performed by Mann-Whitney test, two-tailed.
P < 0.05 is considered significant. N = 13 per cohort.
(13), Bla g 2 was dominant in several studies (13, 22, 23). Previous
studies indicated a different pattern of dominance for T cells, with
Bla g 5 being most dominantly recognized (9).
Here we defined the patterns of Bla g allergen T cell
immunodominance at the individual donor level. As expected,
different patterns of dominance were noted in the different
subjects. Two donors responded predominantly to Bla g 1
(Figure 4A), four donors exhibited Bla g 2-dominant T cell
reactivity (Figure 4B), five donors had highest T cell reactivity in
response to the Bla g 5 pool (Figure 4C) and one donor reacted
most strongly to Bla g 11 (Figure 4D). One donor did not have
a clear allergen-specific T cell response dominance (data not
shown). This data suggests that, similar to IgE (13), allergen T
cell dominance in cockroach allergy is variable as a function of
the specific subject considered.
Discordant Ranking of German Cockroach
Allergic Donors as a Function of Extract
Use
Given this variability in extract potency and the heterogeneity of
Bla g dominance among our cohort, we anticipated that different
extracts would perform differently when used to measure
German cockroach extract-specific T cell responses in different
donors. To exemplify this point, we selected two extracts, one
with high and one with low T cell potency (extract 7 and extract
12, respectively), as previously determined (Figure 2A).
The potency of these 2 extracts was assessed in 3 individual
donors with different Bla g T cell dominance, namely 1424 (Bla g
1 high), 1398 (Bla g 2 high) and 1437 (Bla g 5 high). Interestingly,
ranking of the three individual donors based on T cell response
magnitude returns different result depending on which extract is
used (Figure 5). Extract 7 elicits highest T cell responses in donor
1437 (23,267 SFC at 50µg/ml), followed by 1398 (15,637 SFC at
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FIGURE 4 | Percent T cell reactivity to Bla g-derived peptide pools. Graphs
showing T cell reactivity (sum of IL-5, IFNγ, and IL-10) in individual donors
against each Bla g component peptide pool as percent of the sum of all Bla g
pools. Donors are grouped based on their predominant T cell reactivity for
(A) Bla g 1, (B) Bla g 2, (C) Bla g 5, and (D) Bla g 11. N = 12.
50µg/ml) and then 1424 (12,270 SFC at 50µg/ml). In contrast,
extract 12 yields the exact opposite ranking (1437- 414 SFC, 1398-
414 SFC, 1424- 11,130 SFC at 50µg/ml). Furthermore, while T
cell reactivity against extract 7 is overall high in all donors, extract
12 only elicits robust T cell responses in donor 1424 (Figure 5).
Extract Potency Is Associated With the
Donor-Specific Allergen
Immunodominance and Variation in Extract
Composition
To evaluate if variability in allergen content in different extracts
and heterogeneity in allergen dominance among our study
cohort would explain the disconnect in donor-specific T cell
reactivity patterns between different extracts, we performed
additional analyses. As above, we focused on extract 7 and 12 as
examples of strong and weak inducers of T cell reactivity, and
donors 1424, 1398, and 1437 as representatives of heterogeneous
allergen reactivity.
Analysis of the allergen content revealed that extract 7
contains detectable levels of Bla g 1 (7,770 MS2), 2 (1,690,000
MS2), and 5 (53,100 MS2), while extract 12 contains higher
levels of Bla g 1 (308,000 MS2) and 2 (7,220,000 MS2) but
no Bla g 5 (Figure 6A). Both extracts induced potent T cell
reactivity in donor 1424 (extract 7: 10,0057 SFC; extract 12:
8,983 SFC) (Figure 6B), who exhibits high Bla g 1 reactivity
(38% of total allergen-specific response) and also reacts to Bla g
2 (35%) and 5 (28%). Similarly, donor 1398, who is associated
with dominant Bla g 2 responses (53% of total allergen-specific
response), reacted to both extracts (extract 7: 14,643 SFC; extract
12: 294 SFC), though reactivity to extract 7 was almost 50 fold
higher (Figure 6C). Most strikingly, Bla g 5-dominant donor
1437 (51% of total allergen-specific response attributed to Bla g
5) only reacted to extract 7 (22,270 SFC) and no reactivity was
observed to extract 12 (Figure 6D). This data highlights that the
allergen content of a given extract and the allergen-specific T cell
reactivity pattern in a given donor can have a major impact on
the apparent extract’s potency to measure German cockroach-
specific T cell responses, and the apparent relative reactivity of
different donors might be impacted as a consequence.
DISCUSSION
Here we report that different CR extracts vary drastically in
composition. We further show that this variation has biological
consequence for measurements of T cell responses. Specifically,
this can lead to paradoxically opposite ranking of T cell reactivity
in individual patients. This issue is of high importance, as
it can lead to potentially misleading results and should be
considered during the selection of extracts to be used as
a diagnostic tool, and maybe more importantly for clinical
allergen-specific immunotherapy, and in the interpretation of
immunotherapy results.
We investigated allergen composition and T cell potency of
twelve different German cockroach extracts. Determination of
allergen content by mass spectrometry and ELISA revealed high
variability in Bla g 1, 2, and 5 content. This data is in line with
previous reports for cockroach extracts (12) and other major
allergen sources including dog and house dust mite (24, 25),
reporting high variability in the content of different allergens in
extracts as determined by antibody reactivity.
Antibody-based approaches to measure allergen content are
reliable to determine the amount of allergen able to bind
the antibody. However, any degree of protein degradation or
denaturation that may alter or destroy the specific epitope
recognized by the antibody will ultimately lead to the protein
no longer being detected. This is an important consideration,
especially with respect to T cells, that recognize short peptides
and will still react to fragments of the allergen that may be present
but are no longer detectable by ELISA. Interestingly, Bla g 5
was 100-fold lower in the ELISA indicating that it may be more
degraded and detected less by IgG compared to Bla g 1 and
2. These results suggest that both quantitation approaches have
value, and should perhaps be used in combination.
In addition to the variability in allergen content, an analysis
of the potency of the different extracts tested to induce T
cell reactivity revealed strong differences. Overall, commercially
available extracts produced from whole body for research use
induced strongest T cell responses, whereas extracts made in-
house from fecal matter were weak T cell stimuli. Extracts
approved for clinical use in humans performed better than
extracts made from fecal matter but were several fold less potent
compared to those produced for research purposes. Structural
studies have reported that while some allergens, such as Bla g
1, 2, and 4, are excreted into the feces, others, particularly those
with structural functions such as Bla g 6 and 7 are likely to
be released after decomposition of dead bodies (10). Therefore
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FIGURE 5 | T cell reactivity in three donors in response to two different extracts. Total T cell reactivity (sum of IL-5, IFNγ and IL-10) measured as spot forming cells
(SFC) in response to two selected extracts (extract 7 left; extract 12 right) in three individual donors was assessed.
FIGURE 6 | Content of Bla g 1, 2, and 5 and T cell reactivity in response to two selected German cockroach extracts. (A) Content of Bla g 1, 2, and 5 in extract 7 and
12 as measured by mass spectrometry. (B–D) Total T cell reactivity (sum of IL-5, IFNγ and IL-10) against Bla g 1, 2, and 5 -specific peptide pools and extracts 7 and
12 in three different donors, each dominant for either (B) Bla g 1 (donor 1424), (C) Bla g 2 (donor 1398) or (D) Bla g 5 (donor 1437). Bla g pool responses and extract
responses are segregated by a dashed line. The left axis applies to the Bla g pool responses (left panel), showing percent of T cell response attributed to each
individual Bla g pool. The right axis applies to the extract responses (right panel), showing T cell response magnitude as measured by spot forming cells (SFC).
differences in the extract source material as well as preparation
will likely have a strong impact on the final composition and its
immunological potency.
A potential further source of variability are the antigen
presenting cells (APC). In our assay, we did not control the
number of antigen presenting cells after 14 days. Different
extracts may stimulate APC activation and proliferation to
varying degrees, thus adding another potential source of
variability for T cell reactivity. Interestingly, there was no
direct effect of endotoxin content on T cell reactivity in our
analysis. This may be linked to the fact that T cells themselves
do not express toll like receptors that would directly interact
with endotoxin. Nonetheless, it is highly possible that other
immunological events not directly measured here, such as APC
activation, is highly influenced by endotoxin content.
Interestingly, when comparing T cell reactivity in allergic and
non-allergic individuals in response to the most potent extract, a
significant difference in IL-5 production was detected, indicating
that the extract does maintain its specificity to elicit allergic
responses. In line with other studies (26, 27), we observed no
difference in IFNγ and IL-10 production, suggesting that non-
allergic individuals are not oblivious to environmental allergens
but they do not exhibit a type 2 dominated T cell response as is
commonly observed in allergic individuals.
Allergen sources that contain several different allergens such
as German cockroach or Timothy grass are often associated
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with different patterns of component-resolved T cell reactivity,
depending on the individual patient (9, 21). An investigation
of any potential immunodominance patterns in our cohort
demonstrated that no consistent pattern is observed for Bla
g 1, 2, 4, 5, and 11, confirming that the responses are very
heterogeneous. The resulting unpredictability of which Bla g
is prominently recognized by which donor further highlights
the importance of regulating the allergen content on a single
component level for German cockroach extract, or in a pragmatic
sense, ensuring that all allergens are well represented in the
extract of choice.
Assaying T cell reactivity in a set of patients can have
drastically different outcomes depending on which extract is
used, as the potency of a given extract can vary greatly depending
on which patient is analyzed. Our data suggests that extract
potency in a given patient can be directly linked to the allergen
most dominantly recognized by that patient and the content of
that allergen in the tested extract. This can be of consequence
in the immunotherapy setting. For example it is possible that an
extract high in Blag 5 but low/negative in Bla g 2 content might
be most impactful in modulating T cell responses of a donor
associated with high Bla g 5 reactivity and less Bla g 2 reactivity.
It is tempting to speculate that the considerations reported
here may extend to other common allergen systems. As
mentioned above, extract variability has been reported for other
allergen extracts (24, 25).
Taken together, these data suggest that standardized extract
manufacturing procedures, in parallel with characterization of
extract potency by a combination of methods, including mass
spectroscopy analyses and evaluation of IgE and T cell reactivity
against specific components will be informative and of significant
clinical benefit.
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